Aquaporin‐4 Antibodies ( NMO ‐ IgG ) as a Serological Marker of Neuromyelitis Optica: A Critical Review of the Literature
Year: 2013
Type: review
Abstract: Antibodies to aquaporin-4 (called NMO-IgG or AQP4-Ab) constitute a sensitive and highly specific serum marker of neuromyelitis optica (NMO) that can facilitate the differential diagnosis of NMO and classic multiple sclerosis. NMO-IgG/AQP4-Ab seropositive status has also important prognostic and therapeutic implications in patients with isolated longitudinally extensive myelitis (LETM) or optic neuritis (ON). In this article, we comprehensively review and critically appraise the existing literature on NMO-IgG/AQP4-Ab testing. All available immunoassays-including tissue-based (IHC), cell-based (ICC, FACS) and protein-based (RIPA, FIPA, ELISA, Western blotting) assays-and their differential advantages and disadvantages are discussed. Estimates for sensitivity, specificity, and positive and negative likelihood ratios are calculated for all published studies and accuracies of the various immunoassay techniques compared. Subgroup analyses are provided for NMO, LETM and ON, for relapsing vs. monophasic disease, and for various control groups (eg, MS vs. other controls). Numerous aspects of NMO-IgG/AQP4-Ab testing relevant for clinicians (eg, impact of antibody titers and longitudinal testing, indications for repeat testing, relevance of CSF testing and subclass analysis, NMO-IgG/AQP4-Ab in patients with rheumatic diseases) as well as technical aspects (eg, AQP4-M1 vs. AQP4-M23-based assays, intact AQP4 vs. peptide substrates, effect of storage conditions and freeze/thaw cycles) and pitfalls are discussed. Finally, recommendations for the clinical application of NMO-IgG/AQP4-Ab serology are given.
Source: Brain Pathology
DOI: 10.1111/bpa.12084
Authors: Sven Jarius, Brigitte Wildemann
Institution: Heidelberg University
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: aquaporin-4 antibodies, neuromyelitis optica, serological markers, multiple sclerosis differential diagnosis, longitudinally extensive transverse myelitis, optic neuritis, immunoassay sensitivity and specificity, antibody titers, cerebrospinal fluid analysis, rheumatic diseases, diagnostic testing recommendations
Open Access status: bronze
OpenAlex ID: W2152156112
